← Back to Search

Orthopedic Implant

Vanguard™ Complete Knee System for Osteoarthritis

N/A
Waitlist Available
Research Sponsored by Zimmer Biomet
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 year
Awards & highlights

Summary

The purpose of this prospective clinical data-collection is to document the performance and clinical outcomes of the Vanguard™ Complete Knee System.

Eligible Conditions
  • Osteoarthritis
  • Lower Limb Deformities
  • Joint Replacement Surgery
  • Rheumatoid Arthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
KSS
Secondary outcome measures
Radiographic Information
Survivorship

Trial Design

2Treatment groups
Experimental Treatment
Group I: Vanguard™ Patient-Specific FemurExperimental Treatment1 Intervention
Vanguard Total Knee System used in combination with Signature technique to provide a patient-specific femur
Group II: Vanguard™ Complete Knee SystemExperimental Treatment1 Intervention
Vanguard Total Knee System, Cruciate-Retaining (CR) or Posterior-Stabilized (PS)

Find a Location

Who is running the clinical trial?

Zimmer BiometLead Sponsor
373 Previous Clinical Trials
66,518 Total Patients Enrolled
129 Trials studying Osteoarthritis
32,517 Patients Enrolled for Osteoarthritis
Kacy C Arnold, RN MBAStudy DirectorZimmer Biomet
~34 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top